Sunday, July 8

                   Simultaneous interpretation will be provided during the ISBT Academy Day

                     The ISBT Academy Day is supported by Roche, Haemonetics and Diasorin

08.30 - 10.00      1 - Establishing good practice in difficult settings
08.30 - 09.00      Blood management in disaster situations in Pakistan
                           H.A. Zaheer (Pakistan)
09.00 - 09.30      Challenges in setting up an accreditation system in Africa – what can be
                           learnt
                           B. Armstrong (South Africa)
09.30 - 10.00      The steps taken to establishing a blood service in Chile
                           M. Contreras (United Kingdom)

                           2 - Quality in storage and donation of blood products
08.30 - 09.00      Quality management of blood collection
                           P. Strengers (The Netherlands)
09.00 - 09.30      Quality of blood component processing and storage
                           C. Seidl (Germany)      
09.30 - 10.00      Quality indicators: a tool for quality monitoring and improvement
                           T. Vuk (Croatia)

10.00 - 10.30      Coffee Break

10.30 - 12.00      3 - Treatment of acute, uncontrolled bleeding
10.30 - 11.00      Management of patients with acute bleeding who refuse blood transfusion
                           J. Brooks (USA)
11.00 - 11.30      GI Haemorrhage
                           S. Stanworth (United Kingdom)
11.30 - 12.00      Update on Trauma
                           J. Hess (USA)

                           4 - Blood groups update
10.30 - 11.00      Genetic classification of blood groups
                           J. Storry (Sweden)
11.00 - 11.30      New developments in carbohydrate blood groups
                           M. Olsson (Sweden)
11.30 - 12.00      Protein blood group systems: Berlin and beyond
                           M. Reid (USA)

12.00 - 14.00      Lunch Break

14.00 - 15.30      5 - Disorders of haemostasis and the role of transfusion to their treatment
14.00 - 14.30      TTP/HUS: Modern management
                           J. Kiss (USA)
14.30 - 15.00      Anticoagulants and their reversal: The role of transfusion 
                           J. Wallis (United Kingdom)
15.00 - 15.30      Management of acquired coagulopathies in ITU
                           D. Thomas (United Kingdom)

                           6 - Clinical significance of alloantibodies
14.00 - 14.30      What is a clinically significant antibody?
                           G. Garratty (USA)
14.30 - 15.00      What methods and Process Flow can assist in alloantibody identification?
                           J. Poole (United Kingdom)
15.00 - 15.30      Where do we get blood for difficult cases?
                           M. de Haas (The Netherlands)

15.30 - 16.00      Coffee Break

16.00 - 17.30      7 - Safe plasma products
16.00 - 16.30      GMP for collection of plasma for fractionation
                           J. Wade Atkins (USA)
16.30 - 17.00      Plasma fractionation
                           T. Burnouf (France)
17.00 - 17.30      Needs and availability of plasma derived medicinal products
                           P. Strengers (Netherlands)

16.00 - 17.30      8 - Maternal/fetal relationship
16.00 - 16.30      Pregnancy immunology and maternal alloimmune responses
                           B. Kumpel (United Kingdom)
16.30 - 17.00      Hemolytic disease of the fetus and newborn: From bench to bedside
                           B. Carbonne (France)
17.00 - 17.30      Fetal and neonatal alloimmune thrombocytopenia: from bench to bedside
                           C. Kaplan (France)

17.45 - 18.45      Opening Ceremony
18.45 - 21.00      Opening of the Trade Exhibition and Welcome Reception